Introduction to the tumour microenvironment review series.
Lawler, Jack. 2009. “Introduction to the Tumour Microenvironment Review Series.”. Journal of Cellular and Molecular Medicine 13 (8A): 1403-4.
Search
Search results
2993 results found
The crystal structure of the heparin-binding reelin-N domain of f-spondin.
Tan, Kemin, Mark Duquette, Jin-huan Liu, Jack Lawler, and Jia-huai Wang. 2008. “The Crystal Structure of the Heparin-Binding Reelin-N Domain of F-Spondin.”. Journal of Molecular Biology 381 (5): 1213-23.
Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets.
Olerud, Johan, Magnus Johansson, Jack Lawler, Nils Welsh, and Per-Ola Carlsson. 2008. “Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets.”. Diabetes 57 (7): 1870-7.
Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease.
Punekar, Salman, Samantha Zak, Valerie G Kalter, Larissa Dobransky, Imran Punekar, Jack W Lawler, and Linda S Gutierrez. 2008. “Thrombospondin 1 and Its Mimetic Peptide ABT-510 Decrease Angiogenesis and Inflammation in a Murine Model of Inflammatory Bowel Disease.”. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology 75 (1): 9-21.
Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins.
Chen, Faye Hui, Ashby O Thomas, Jacqueline T Hecht, Mary B Goldring, and Jack Lawler. 2005. “Cartilage Oligomeric Matrix Protein/Thrombospondin 5 Supports Chondrocyte Attachment through Interaction With Integrins.”. The Journal of Biological Chemistry 280 (38): 32655-61.
Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/alphavbeta3 in promyelocytic leukemia NB4 cells.
Saumet, Anne, Mouna Ben Slimane, Michel Lanotte, Jack Lawler, and Véronique Dubernard. 2005. “Type 3 Repeat/C-Terminal Domain of Thrombospondin-1 Triggers Caspase-Independent Cell Death through CD47/Alphavbeta3 in Promyelocytic Leukemia NB4 Cells.”. Blood 106 (2): 658-67.
Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
Frangogiannis, Nikolaos G, Guofeng Ren, Oliver Dewald, Pawel Zymek, Sandra Haudek, Anna Koerting, Kim Winkelmann, Lloyd H Michael, Jack Lawler, and Mark L Entman. 2005. “Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts.”. Circulation 111 (22): 2935-42.
Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model.
Zhang, Xuefeng, Eric Galardi, Mark Duquette, Marko Delic, Jack Lawler, and Sareh Parangi. 2005. “Antiangiogenic Treatment With the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein in an Orthotopic Human Pancreatic Cancer Model.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 11 (6): 2337-44.
Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease.
Ibanez, Laura, Jorge A Bahena, Chengran Yang, Umber Dube, Fabiana H G Farias, John P Budde, Kristy Bergmann, et al. 2020. “Functional Genomic Analyses Uncover APOE-Mediated Regulation of brain and Cerebrospinal Fluid Beta-Amyloid Levels in Parkinson Disease.”. Acta Neuropathologica Communications 8 (1): 196.
Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss.
Benitez, Bruno A, Nigel J Cairns, Robert E Schmidt, John C Morris, Joanne B Norton, Carlos Cruchaga, and Mark S Sands. 2015. “Clinically Early-Stage CSPα Mutation Carrier Exhibits Remarkable Terminal Stage Neuronal Pathology With Minimal Evidence of Synaptic Loss.”. Acta Neuropathologica Communications 3: 73.